Author Archive
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its
By Kieran Guilbert GADO-BADZERE, Cameroon (Thomson Reuters Foundation) - Alone, hungry and traumatised having watched her parents die in war-torn Central African Republic, 14-year-old Koulsoumi believed the worst was behind her when she was taken in by
(Reuters) - Valeant Pharmaceuticals International Inc reported a smaller-than-expected quarterly adjusted profit due to faltering sales of its dermatology products and irritable bowel syndrome drug, and the company cut its full-year profit and revenue forecasts. Valeant's
A U.S. citizen who was detained for more than a year and a half by the Houthi faction in Yemen has been released, Secretary of State John Kerry said on Sunday. Wallead Yusuf Pitts Luqman was freed
By Philip Pullella VATICAN CITY (Reuters) - Prisoners from around the world attended a special Mass by Pope Francis on Sunday, hearing him call for society to put more trust in rehabilitation, improved jail conditions and
BERLIN (AP) — German prosecutors have widened their investigation into Volkswagen's handling of the emissions scandal to include its board chairman, Hans Dieter Poetsch, the company said Sunday.
NEW DELHI (AP) — Even for a city considered one of the world's most polluted, the Indian capital hit a new low this past week.
By Robin Respaut SAN FRANCISCO (Reuters) - Californians are expected to pass a ballot measure on Election Day legalizing recreational marijuana, and the prospect has cities and counties seeing dollar signs. Proposition 64 would impose state
The effectiveness of Cempra Inc's antibiotic to treat community-acquired pneumonia outweighs the risk of liver injury, an advisory panel to the U.S. Food and Drug Administration narrowly concluded on Friday. The panel voted 7-6 that the drug,
The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs. U.S. prosecutors could